Ottobock SE & Co. KGaA / DE000BCK2223

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
  Duderstadt, 10 October 2025
  The global MedTech champion is writing the next chapter of its success story. Ottobock shares debut successfully on the Frankfurt Stock Exchange with a first trading price of EUR 72.00. Proceeds from the IPO will be used, among other things, for investments into innovative future technologies. Around 200 employees and product users celebrate in front of the Frankfurt Stock Exchange.   Germany’s MedTech champion Ottobock made a strong debut on the stock market on 9 October 2025. The IPO was marked by the symbolic ringing of the bell on the trading floor of the Frankfurt Stock Exchange. With a first trading price of EUR 72.00, Ottobock sent a strong signal and began a new chapter as a publicly listed company. “More than 100 years of innovation and ingenuity have brought us to this point. Ottobock has continuously reinvented itself and the O&P industry. Today, we warmly welcome our new shareholders. We are excited to continue our path of success together. What began as a family business, we now continue as a listed company – driven by dedicated employees, long-standing partners, my family, and many new shareholders,” said Prof. Hans Georg Näder, Chairman of the Board and still majority owner of Ottobock. “Together, we are taking the next step to continue revolutionising our industry with pioneering technologies.” Oliver Jakobi, Chief Executive Officer of Ottobock, added: “We have successfully taken Ottobock public. The attractive valuation reflects the potential investors see in us and our mission: helping people maintain or regain their freedom of movement. With the additional capital raised through today’s IPO, we will, among other things, invest specifically in future technologies, further develop the human-machine interface, and expand our global patient care network.” Festive atmosphere in front of the stock exchange Around 200 Ottobock employees, product users, and family members gathered in front of the Frankfurt Stock Exchange to witness the announcement of the first trading price. Near the iconic bronze bull and bear statues, they were treated to a live concert by Sam Ryder. The British singer delivered a goosebump moment with his performance of “Mountain” – a song he composed for Ottobock in 2023 and first performed live at the Eurovision Song Contest. It’s a hymn that celebrates life. IPO proceeds to fund new innovations in MedTech A total of 12,236,173 shares were placed as part of the IPO. Based on the offer price of EUR 66.00 the market capitalization of Ottobock SE & Co. KGaA amounts to approximately EUR 4.2 billion. Proceeds from the sale of new shares through a capital increase total approximately EUR 100 million.   Photos and videos are available for download at: Recording of the Frankfurt Stock Exchange to the IPO ceremony Further photos for download   Investor contact: Ottobock SE & Co. KGaA
Julia Hartmann
VP Investor Relations
Mobile +49 151 556 848 07
Julia.Hartmann@ottobock.de
  Media contacts: Ottobock SE & Co. KGaA
Merle Florstedt     
Head of Corporate Communications  
Mobile +49 151 441 616 25 Merle.Florstedt@ottobock.de   About Ottobock Ottobock, a global MedTech champion, combines over 100 years of tradition with outstanding innovative strength in the fields of prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative fitting solutions for people with limited mobility and is driving the digitalisation of the industry. Founded in Berlin in 1919, the company has business activities in 45 countries with nearly 9,300 employees (FTEs) worldwide and operates the largest international patient care network with around 400 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock’s mission of improving freedom of movement, quality of life and independence is deeply rooted in the company's DNA, as is its social commitment: Ottobock has been a partner and supporter of the Paralympics since 1988.   Important Notice This announcement is not and does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America, Australia, Canada or Japan, or any other jurisdiction in which such offer may be restricted. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, or otherwise transferred, directly or indirectly, in or into the United States of America absent such registration, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the Securities Act, and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the securities in the United States of America. This announcement is an advertisement and not a prospectus. Investors should not purchase or subscribe for any securities in Ottobock SE & Co. KGaA (“Ottobock” or the “Company”) referred to in this announcement except on the basis of information in the prospectus issued by the company in connection with the offering of such securities. Copies of the prospectus are available free of charge from the issuer or on https://investors.ottobock.com. The approval of the prospectus by the German Financial Supervisory Authority (BaFin) should not be understood as an endorsement of the securities. It is recommended that potential investors read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the securities. This announcement is directed at and/or for distribution in the United Kingdom only to (i) persons who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities falling within article 49(2)(a) to (d) of the Order (all such persons are referred to herein as “relevant persons”). This announcement is directed only at relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons. Forward-looking Statements This announcement may contain “forward-looking statements”. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as “will”, “anticipates”, “aims”, “could”, “may”, “should”, “expects”, “believes”, “intends”, “plans”, “prepares” or “targets” (including in their negative form or other variations). By their nature, forward-looking statements are inherently predictive, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. There are a number of factors that could cause actual results, performance and developments to differ materially from those expressed or implied by these forward-looking statements. All subsequent written or oral forward-looking statements attributable to Ottobock or its respective affiliates, or any persons acting on their behalf are expressly qualified in their entirety by the factors referred to above. No assurances can be given that the forward-looking statements in this document will be realised. Any forward-looking statements are made of the date of this announcement. To cover potential over-allotments, Näder Upside Vermögensverwaltungs GmbH (the “Selling Shareholder”) has agreed to make available a specified number of Company's shares to the underwriters. In addition, the Selling Shareholder has granted underwriters an option to acquire a number of the Company’s shares equal to the number of shares allotted to cover over-allotments during the Stabilization Period (as defined below). In connection with the placement of the Company’s shares, Goldman Sachs Bank Europe SE will act as the stabilization manager and may, as stabilization manager, make over-allotments and take stabilization measures in accordance with legal requirements (Art. 5(4) and (5) of Regulation (EU) No 596/2014 in conjunction with Articles 5 through 8 of Commission Delegated Regulation (EU) 2016/1052) to support the market price of the Company’s shares and thereby counteract any selling pressure. The stabilization manager is under no obligation to take any stabilization measures. Therefore, stabilization may not necessarily occur and may cease at anytime. Such measures may be taken on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) from the date when trading in the Company’s shares is commenced on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), expected on or around October 9, 2025, and must be terminated no later than 30 calendar days after this date (the "Stabilization Period"). Stabilization transactions aim at supporting the market price of Company’s shares during the Stabilization Period. These measures may result in the market price of Company's shares being higher than would otherwise have been the case. Moreover, the market price may temporarily be at an unsustainable level. The information contained in this release is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this release or its accuracy, fairness or completeness. The date of the admission to trading of shares of Ottobock on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) with simultaneous admission to the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) (together, the "Admission") may be influenced by things such as market conditions. There is no guarantee that Admission will occur and no financial decision should be based on the intentions of Ottobock in relation to Admission at this stage. Acquiring investments to which this release relates may expose an investor to a significant risk of losing all of the amount invested. Persons considering making such investments should consult an authorised person specializing in advising on such investments. This release does not constitute a recommendation concerning the Offering. The value of shares can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the Offering for the person concerned.